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Abstract
Background: To compare radiographic measurement and pathological measurement of renal
tumours to see if there was a significant difference between the two as this may have implications
in the management.
Methods:  We retrospectively analyzed CT measurements of 106 consecutive patients who
underwent either radical or nephron sparing surgery in our institution and compared this to the
actual measurement of the surgical specimen. The largest axial measurement was compared as this
is the primary consideration before offering either treatment modality.
Results: The mean age of the patients was 64 years (range 31–92). There were 76 males and 30
females. The median tumour size was 70 mm (range 16–175) on CT and 65 mm (range 15–90) on
pathological measurement. 25 patients had a CT size ≤ 40 mm. CT tended to overestimate the size
of tumours in 41 patients, underestimate in 45 and agree with surgical size in 20 patients.
Statistically there was no significant difference between the two measurements (p = 0.7, Wilcoxon
sign ranked test). When subdivided into tumours less than 40 mm (p = 0.7) and more than 40 mm
(p = 0.09) again there was no statistically significant difference between the two measurements.
However in 5(5%) patients who were not offered nephron sparing surgery based on CT findings
(size > 40 mm) the pathological size was ≤ 40 mm (p = < 0.001, Fishers Exact test). Pathologically
the tumours were classified as renal cell carcinoma (n = 98), angiomyolipoma (3), and oncocytoma
(5).
Conclusion: CT measurement of renal tumour size correlates well with the actual size of the
tumour. However CT does tend to overestimate the size in a small number of patients which may
have a bearing on the modality of treatment offered.
Published: 4 November 2008
BMC Urology 2008, 8:13 doi:10.1186/1471-2490-8-13
Received: 21 December 2007
Accepted: 4 November 2008
This article is available from: http://www.biomedcentral.com/1471-2490/8/13
© 2008 Mistry et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Urology 2008, 8:13 http://www.biomedcentral.com/1471-2490/8/13
Page 2 of 5
(page number not for citation purposes)
Background
Radical nephrectomy is the standard treatment for local-
ized renal cell carcinoma (RCC) in patients with a normal
contra lateral kidney. However, in patients with a solitary
functioning kidney, nephron sparing surgery (NSS) is
mandatory [1]. NSS is also desirable in benign renal
tumours such as angiomyolipoma [2]. It therefore should
also be considered when there is uncertainty about the
diagnosis because of the possibility of a benign renal
tumour, angiomyolipoma or a complex cyst. In recent
years, NSS has also been proposed for RCC with a normal
contra-lateral kidney with excellent five year cancer-spe-
cific survival results being reported [3-5]. Such a surgical
option is particularly suited for small RCCs, which seem
to be best suited for renal sparing surgery [6]. In fact, with
the advent and development of ultrasound and computer-
ized tomography (CT), small RCCs are being detected
with increasing frequency [7,8]. With this increase of
number, there has been a decrease in the average size of
tumours found [7,8]. The relationship between the clini-
cal and pathologic size of renal tumours has been studied
before with variable results [9-14]. Some of studies sug-
gested preoperative CT imaging may overestimate the
pathologic size, which may have implications for plan-
ning NSS [9-13]. Our aim was to determine what extent
do CT measurements over or under-estimate the size of
small renal tumours and how it can impact of their man-
agement.
Methods
We retrospectively identified 106 consecutive patients
who underwent a radial nephrectomy or NSS for a sus-
pected renal tumour between the years 2000 and 2006.
All patients underwent a contrast enhanced CT scan and
pathological examination of the specimen at one institu-
tion. Data on the CT measurements were taken from the
radiology reports. The CT device used and the grade of the
reporting Radiologist was noted. The CT scans were
reviewed by a team of Radiologists with a special interest
in urology. Eighty eight percent (93) of the CT scans were
reported by Consultant Radiologists and 12% (13) by
Registrars. 48% (51) of tumours were scanned using a sin-
gle slice helical scanner (GE CT Lxi™, GE Healthcare, Giles,
UK) with the images viewed on 7 mm slices; 21% (22)
with a single slice non helical scanner (GE Hispeed advan-
tage™, GE Healthcare, Giles, UK) with images viewed on 5
mm slices and 31% (33) with a 16 slice helical scanner
(Siemens Sensation™, Siemens Medical Solutions, Frim-
ley, UK) with the images reconstructed and viewed on 1
mm slices.
The resected specimen was analysed by a single Urological
Histopathogist. The tumour was orientated and transected
as per the Pathological cut-up protocol with the macro-
scopic dimensions being measured using a ruler.
For both the CT scan and the surgical tumor specimen, the
largest transaxial or transverse diameter, respectively, was
used to measure the size of the tumor, using either ruler.
One measurement of maximum tumor diameter was
used, since it is equivalent to the bi-dimensional measure-
ment to assess changes in solid tumors, even for non-
spherical tumours.
The largest axial dimension was recorded from the CT
report. This was then compared to the actual measure-
ment taken from the histopathological report. Figure 1
shows the CT picture of a left lower pole renal tumour and
Figure 2 shows the resected specimen of the same tumour.
Pathologically the tumours were classified as renal cell
carcinoma, angiomyolipoma, and oncocytoma. These
two comparable dimensions were analysed using the Wil-
coxon sign ranked test and the Fishers Exact test.
Results
106 patients were identified as having a radical nephrec-
tomy or nephron sparing surgery. This included 76 males
and 30 females with a mean age 62 years (range 31–92).
Of the 106 tumours excised, 98 (92%) were classified as
renal cell carcinoma, 3 (3%) angiomyolipoma, and 5
(5%) oncocytoma.
The median tumour size was 70 mm (range 16–175) on
CT and 65 mm (range 15–90) on pathological measure-
ment. 22 patients had a CT size ≤ 40 mm. CT tended to
overestimate the size of tumours in 41 patients, underes-
timate in 45 and agree with surgical size in 20 patients.
Statistically there was no significant difference between
the two measurements (p = 0.7, Wilcoxon sign ranked
test). When subdivided into tumours less than 40 mm (p
= 0.7) and more than 40 mm (p = 0.09) again there was
CT picture of a left lower pole renal tumour (T) Figure 1
CT picture of a left lower pole renal tumour (T).BMC Urology 2008, 8:13 http://www.biomedcentral.com/1471-2490/8/13
Page 3 of 5
(page number not for citation purposes)
no statistically significant difference between the two
measurements. However in 5 (5%) patients who were not
offered nephron sparing surgery based on CT findings
(size > 40 mm) the pathological size was ≤ 40 mm (p = <
0.001, Fishers Exact test). When further subdivided into
various size ranges the difference between CT and pathol-
ogy are shown in Table 1 and 2. In general CT tended to
overestimate tumours less than 70 mm and underestimate
tumours greater than 70 mm.
Discussion
The importance of the size of renal tumours when consid-
ering NSS is increasingly becoming more apparent. Since
the numbers of incidentally discovered tumours are up to
25–40% in developed countries, there is an increasing
demand for NSS[8]. In fact these patients are being
detected incidentally during routine health care screening
programs, whereas historically most cases were diagnosed
following investigations for flank pain or hematuria[15].
The rising trend that has been observed is primarily due to
enhanced detection by widely used non-invasive imaging
techniques, such as ultrasonography and computer tom-
ography (CT) [16]. These incidentally discovered RCCs
have tended to be smaller and of a low pathological stage
than those detected in symptomatic patients. Improved
survival has been demonstrated in these patients, com-
pared with those with symptomatic tumour presentations
[4,17].
Patients who have incidental renal tumours less than 40
mm cm treated with NSS have been shown to have a bet-
ter outcome than those with tumours greater than 40 mm,
with the 5 year disease-free survival rate being 95–
100%[4,18]. Whilst this study used the pathologic size in
determining the appropriate size cut-off for NSS, it is the
radiographic size that is used in routine practice when
considering NSS. However the use of 40 mm as a rigid cut
off point is changing as Patard et al [19] have shown no
difference in the cancer specific death rates in patients
undergoing radical or partial nephrectomy for tumours
between 40 mm and 70 mm (9% vs.6.2%, p < 0.6).
While there is increased detection of these small renal
masses, an accurate pre-operative diagnosis can often be
difficult with inter-radiologist variation in CT reporting
techniques. Some CT scanners allow 3-dimensional
reconstruction with the aid of a multi-slice scanners (e.g.
Siemens 16 slice Sensation helical scanner), whilst others
simply allow only a 2-dimensional measurement with an
estimate of the 3rd dimension on single slice machine.
Punnen et al assessed 29 renal masses measured by three
radiologists in three different planes: axial, perpendicular
and superior-inferior obtained using a 4-slice, multirow
helical CT scanner [20]. The inter-reader and intra-reader
variability in the size of measurements found the highest
variance between and within readers was in the superior-
inferior axis. This axis was displayed from reconstructed
images, making it more difficult to define the edges of the
mass along that dimension. The least inter-observer and
intra-observer variability was noted in the axial diameter;
Same tumour after nephrectomy (T) Figure 2
Same tumour after nephrectomy (T).
Table 1: Comparison between pathological and CT size
Pathologic Size in mm Number of patients Mean CT size (mm) Pathological size (mm) Difference % Difference p value 
(Wilcoxon sign Ranked 
Test)
10 to < 20 2 27 15.5 12.5 80 0.18
20 to < 30 6 25.5 25 0.5 2 0.09
30 to < 40 9 41 31.9 9.1 28 0.23
40 to < 50 11 44.5 42.3 2.2 5.2 0.6
50 to < 60 10 47.2 53.3 -6.1 -11 0.02
60 to < 70 20 69.3 61.8 7.5 12 0.05
≥ 70 48 95 101.8 -6.8 -6.6 0.06
Total 106 49.9 47.37 2.53 5.3BMC Urology 2008, 8:13 http://www.biomedcentral.com/1471-2490/8/13
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however there was only one tumour between 3 and 4 cm
included in this study.
According to Steinbach and associates [2], the specificity
of the CT scan in the diagnosis of small renal tumours is
between 85% and 90%; they also noted that the differen-
tiation of oncocytoma, adenomas and haemorrhagic cysts
could be problematic. Jamis-Dow et al[10] noted that for
10–35 mm lesions, 80% and 82% were correctly charac-
terized with CT and ultrasound, respectively (n = 205).
Several studies have examined the relationship between
the radiographic and pathologic tumour size [9-13].
Schlomer et al [13] retrospectively identified 126 patients
who underwent a nephrectomy or NSS with in 60 days of
CT scanning and found that the scans tended to overesti-
mate the size of pT1a (p = 0.009) and pT1b tumours (p =
0.087) and underestimate tumours > 70 mm. Our study
concurs with their findings (Table 2). Herr [9] looked at
50 patients who underwent NSS who had CT scans within
4 weeks of the surgery. They found that tumours were a
mean of 6.3 mm smaller than the CT scans stated. This
was particularly noticeable in the tumours ≥ 35 mm, with
a mean decrease of 9.5 mm (n = 17). This difference was
attributed to the shrinkage of the tumours by temporary
renal artery occlusion and surface hypothermia. In
another study by the same author, of the 87 incidentally
identified renal tumours, clear cell carcinomas decreased
on average of 9.7 mm (p = 0.0001) versus 39 mm (p =
0.0001) for the other tumours[11]. They also found that
tumours > 30 mm, there was a change of 8.7 mm (p =
0.001) when compared to the pathological size. Irani et al
[12] analysed 100 patients who underwent radical
nephrectomies and found that CT estimate and surgical
measurement of tumour were highly correlated (r = 0.9; p
< 0.001). The median tumour size on CT was 70 mm com-
pared to 60 mm on pathological sampling, with a signifi-
cant difference (p = 0.005). Yaycioglu et al [14]
retrospectively looked at 291 nephrectomies and found a
high correlation between the clinical and pathological
size (p < 0.0001).
Patients in our institution were offered NSS if the maximal
diameter of the renal tumour was less than 40 mm on the
CT scan as per protocol.
Conclusion
Our retrospective study supports the findings of previous
studies with 41 (39%) patients having an overestimation
of the size (ns). However, in 5 (5%) patients who were not
offered NSS based on CT findings (size > 40 mm) the
pathological size was ≤ 40 mm (p < 0.001, Fishers Exact
test). This may therefore have had a bearing on the treat-
ment options offered to the patients. Accurate CT meas-
urements of renal tumours play a vital role in deciding
whether to proceed with NSS or not in this group of
patients, therefore our protocol is under revision to incor-
porate this variance in CT interpretation as it may affect
the surgical decision making.
Since our data was retrospectively reviewed, the results are
subject to an observational variability. Our discrepancies
might have been caused by the lack of standardization in
the radiologic and pathologic measurement techniques.
As well as the use of three different radiographic imaging
equipment, the tumours maximal dimensions may well
have not been measured in the same geometric plane
therefore producing errors in comparison. Ideally in the
future, a single multi-slice helical scanner should be used
with a single radiologist reporting. Our study can be
improved with a power calculation as the number
patients and tumours were small. This study should be
followed up by a multicentre prospective study with pre-
set protocols for assessing the CT and Pathological meas-
urements.
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Table 2: Comparison between CT and Pathology when Tumours are stratified according to the TNM criteria
Pathological Stage 
(size in mm)
Number of Patients Mean CT size (mm) Mean Pathological size 
(mm)
Difference (mm) Difference % p value
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